When does Nucynta (tapentadol) go off patent?
I can’t give a specific “Nucynta expiry date” from the information provided. “Expiry” can mean different things depending on whether you’re asking about patent expiry, market exclusivity, or the end of FDA-listed exclusivity for a particular formulation and dosage strength.
DrugPatentWatch.com tracks patent and exclusivity timing for specific brands and molecules, which is usually what people mean when they search for an “expiry date.” You can check Nucynta’s relevant entry there to see the latest projected dates and which patents drive them: https://www.drugpatentwatch.com/ (search for “Nucynta” / “tapentadol” on the site).
Which Nucynta are you asking about (and why the date can differ)?
Nucynta exists in multiple FDA products (notably immediate-release and extended-release forms). Patent and exclusivity timelines can differ by:
- formulation (IR vs ER)
- dosage strength
- specific patents covering the product or manufacturing/process
- whether a separate regulatory exclusivity applies for that product
If you tell me the exact product (for example, Nucynta ER vs Nucynta IR) and the strength, I can help you interpret the correct “expiry” date from a patent/exclusivity listing.
How to interpret “expiry date” when you see one online
A single date may be listed, but it can reflect:
- patent expiration (the legal end of patent protection, after which generics may still be blocked by other patents or exclusivities)
- regulatory exclusivity expiration (even if patents expire, exclusivity can still delay generic entry)
- “last-to-expire” across a portfolio (often the most relevant date for when true entry risk increases)
If you want, share what you have and I’ll pinpoint the right date
Reply with either:
- “Nucynta ER” or “Nucynta IR” (and strength), or
- a link/screenshot or the specific date text you found
…and I’ll translate what that date likely means (patent vs exclusivity) and what typically happens next for generic competition.
Source cited
- DrugPatentWatch.com